Nadège. Briançon, et.al., In vivo role of the HNF4alpha AF-1 activation domain revealed by exon swapping., The EMBO journal, 2006, 25

http://rdf.ncbi.nlm.nih.gov/pubmed/16498401

Nadège. Briançon, et.al., In vivo role of the HNF4alpha AF-1 activation domain revealed by exon swapping., The EMBO journal, 2006, 25

http://rdf.ncbi.nlm.nih.gov/pubmed/

トランスクリプトームデータ

http://rdf.ncbi.nlm.nih.gov/pubmed/

• CD01017
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD01017
• CD20830
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD20830
• CD21413
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD21413

allele

http://purl.org/net/cito/citesAsAuthority

• Hnf4a<tm1Mwei>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3625863
• Hnf4a<tm2Mwei>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3625865
• Hnf4a<tm1.1Mwei>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3622273
• Hnf4a<tm2.1Mwei>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3622274

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• decreased circulating cholesterol level_Hnf4a<tm2.1Mwei>/Hnf4a<tm2.1Mwei>
  http://metadb.riken.jp/0005179I129S2SvPasBALBcC57BL6Hnf4atm21MweiHnf4atm21MweiHnf4atm21Mwei
• decreased circulating free fatty acid level_Hnf4a<tm2.1Mwei>/Hnf4a<tm2.1Mwei>
  http://metadb.riken.jp/0002702I129S2SvPasBALBcC57BL6Hnf4atm21MweiHnf4atm21MweiHnf4atm21Mwei
• impaired glucose tolerance_Hnf4a<tm1.1Mwei>/Hnf4a<tm1.1Mwei>
  http://metadb.riken.jp/0005293I129S2SvPasBALBcC57BL6Hnf4atm11MweiHnf4atm11MweiHnf4atm11Mwei
• abnormal lipid homeostasis_Hnf4a<tm2.1Mwei>/Hnf4a<tm2.1Mwei>
  http://metadb.riken.jp/0002118I129S2SvPasBALBcC57BL6Hnf4atm21MweiHnf4atm21MweiHnf4atm21Mwei
• decreased circulating iron level_Hnf4a<tm2.1Mwei>/Hnf4a<tm2.1Mwei>
  http://metadb.riken.jp/0004151I129S2SvPasBALBcC57BL6Hnf4atm21MweiHnf4atm21MweiHnf4atm21Mwei
• hypokalemia_Hnf4a<tm2.1Mwei>/Hnf4a<tm2.1Mwei>
  http://metadb.riken.jp/0004119I129S2SvPasBALBcC57BL6Hnf4atm21MweiHnf4atm21MweiHnf4atm21Mwei
• increased circulating ketone body level_Hnf4a<tm2.1Mwei>/Hnf4a<tm2.1Mwei>
  http://metadb.riken.jp/0002575I129S2SvPasBALBcC57BL6Hnf4atm21MweiHnf4atm21MweiHnf4atm21Mwei
• hepatic steatosis_Hnf4a<tm2.1Mwei>/Hnf4a<tm2.1Mwei>
  http://metadb.riken.jp/0002628I129S2SvPasBALBcC57BL6Hnf4atm21MweiHnf4atm21MweiHnf4atm21Mwei
• embryonic lethality, complete penetrance_Hnf4a<tm2Mwei>/Hnf4a<tm2Mwei>
  http://metadb.riken.jp/0011092I129S2SvPasC57BL6Hnf4atm2MweiHnf4atm2MweiHnf4atm2Mwei
• increased circulating bilirubin level_Hnf4a<tm2.1Mwei>/Hnf4a<tm2.1Mwei>
  http://metadb.riken.jp/0005344I129S2SvPasBALBcC57BL6Hnf4atm21MweiHnf4atm21MweiHnf4atm21Mwei
• no abnormal phenotype detected_Hnf4a<tm1Mwei>/Hnf4a<tm1Mwei>
  http://metadb.riken.jp/0002169I129S2SvPasC57BL6Hnf4atm1MweiHnf4atm1MweiHnf4atm1Mwei
• decreased circulating triglyceride level_Hnf4a<tm2.1Mwei>/Hnf4a<tm2.1Mwei>
  http://metadb.riken.jp/0002644I129S2SvPasBALBcC57BL6Hnf4atm21MweiHnf4atm21MweiHnf4atm21Mwei